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Summary
Aim: To preserve viable, metabolically active chondrocytes cultured in alginate beads at −196°C for further use in in vitro and in vivo studies.
Methods: Human articular chondrocytes were isolated from femoral condyles within 24 h post mortem. To optimize the biological freezing
procedure, the chondrocytes were control-rate frozen in different concentrations of dimethyl sulfoxide (DMSO) in Dulbecco’s MEM
supplemented with 10% FCS before being thawed and the cell viability was determined by Trypan Blue exclusion test. To investigate the
effect of control-rate freezing on chondrocyte metabolism, control-rate frozen chondrocytes in 5% DMSO were thawed and cultured in gelled
agarose for 2 weeks. Non-frozen chondrocytes cultured in agarose served as controls. Furthermore, human articular chondrocytes were
cultured in 2% alginate beads for 2 weeks after which the beads were incubated with 5% DMSO for 0 h, 2.5 h, 5 h and 10 h and frozen at
−196°C. Non-frozen alginate beads containing chondrocytes and incubated with 5% DMSO served as a control. After 2 weeks in culture,
chondrocytes in agarose or in alginate were sulfated with 10 Ci 35SO4/ml for 48 h. The total production of aggrecans, and the aggrecan
subtypes, were subsequently determined.
Results: Five percent DMSO in the culture medium was the optimal condition to control-rate freeze and recover viable and functional isolated
chondrocytes. Total aggrecan synthesis of control-rate frozen chondrocytes cultured in gelled agarose was not significantly reduced when
compared with control cells. The proportion of aggrecan in the aggregate form of control-rate frozen chondrocytes kept in agarose remained
unaltered. Chondrocytes, control-rate frozen in the alginate matrix, showed a 0–30% decrease in total aggrecan synthesis rates in culture
when compared with the non-frozen chondrocytes. The optimal pre-incubation time of the alginate beads with 5% DMSO was 5 h, without
any change in aggrecan synthesis rates when compared with the control situation. Shorter pre-incubation times resulted in an insufficient
diffusion of DMSO into the beads and in cell death. There was no difference in the synthesis of the different aggrecan subtypes between
frozen and non-frozen chondrocytes in alginate.
Conclusion: Human articular chondrocytes can be stored at −196°C for 24 h without important decreases in their aggrecan synthesis rates
when control-rate frozen as a cell suspension in 5% DMSO. Proportions of the aggrecan subtypes (monomers, aggregates) synthesized by
chondrocytes cultured in agarose remained unchanged. The control-rate freezing procedure in the alginate beads pre-incubated with 5%
DMSO for 5 h produced no decrease in total aggrecan synthesis rates and no change in the synthesized aggrecan subtypes. Further
experiments have to confirm the suitability of this freezing method for long-term storage of chondrocytes allowing us to set up a ‘chondrocyte’
bank for further use in in vitro and in vivo manipulations. © 2001 OsteoArthritis Research Society International
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Adult articular cartilage is a connective tissue populated by
chondrocytes embedded in a dense extracellular matrix
composed of a collagenous fibre network. It contains pre-
dominantly type II collagen but also smaller amounts of
types VI, IX and XI and negatively charged aggrecans,
which aggregate in a large number on a hyaluronan chain
to form aggrecan aggregates. These aggregates generate
a high osmotic pressure, due to their negative charge, with
a maximal expansion of the collagenous matrix. The inter-
cellular matrix of mature cartilage can be divided into three
compartments: the pericellular matrix is a thin layer close to
the chondrocyte, which is rich in aggrecans; the territorial341matrix lies adjacent to the pericellular matrix and together
they form the cell-associated matrix (CAM). The largest
domain is formed by the interterritorial matrix (ITM)1.
Articular chondrocytes can be cultured in monolayer
condition2 or in gelled medium (collagen3,4, fibrin5, agar-
ose2,6). Recently chondrocytes have been cultured in algi-
nate7, a biocompatible and biodegradable8,9 naturally
derived linear polysaccharide composed of (1–4)-linked
beta-D-mannuronic acid (M units) and alpha-L-guluronic
acid (G units)10. Divalent cations (Ca+ +, Ba+ +, . . .) bind
between the G-units forming ionic interchain bridges, which
provoke immediate gelling of the aqueous alginate solu-
tion11. Cultivated in this medium at a concentration of 1.2%
alginate, articular chondrocytes keep their phenotype for up
to 8 months12,13.
Compared with the other artificial matrices mentioned,
the advantage of alginate is the reversibility of the Ca+ +-
alginate binding, which is solubilized when a chelator is
added to the gel. This allows the study of the CAM as well
as of the ITM1.
Freezing of viable cartilage as a tissue has not been
successful because the dense matrix prevents the cryo-
preservant from penetrating into the cells14. However,
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have been successfully frozen. A high viability of these
chondrocytes after thawing has been reported15. The
present study was undertaken to investigate biological
freezing of human articular chondrocytes cultured in algi-
nate. Aggrecan synthesis rates were analysed to evaluate
the effects of the freezing procedure on chondrocyte inter-
cellular matrix metabolism. The purpose of the experiments
was to obtain a ‘chondrocyte’ bank of human articular
chondrocytes for further use in in vitro and in vivo
manipulations.Material and methods
ISOLATION OF ARTICULAR CHONDROCYTES
Human articular chondrocytes were isolated as
described elsewhere16,17, with a few modifications. Briefly,
human articular cartilage was obtained at autopsy from
femoral condyles of different donors within 24 h post mor-
tem. All donors had died after a short illness. None of them
had received corticosteroids or cytostatic drugs. Visually
intact cartilage was harvested and prepared for culture.
Cartilage removed from the femoral condyles was diced
into small fragments and the chondrocytes were isolated by
sequential enzymatic digestion of the extracellular matrix
in a spinner bottle. All enzymatic solutions were made
in Dulbecco’s modified Eagle’s medium (DMEM; Gibco,
Rockville, U.S.A.) with antibiotics and antimycotics (penicil-
lin 10 U/ml; streptomycin 10 g/ml; fungizone 0.025 mg/ml;
Gibco), 0.002 M L-glutamine (Gibco) and 10% of fetal calf
serum (FCS).
The cartilage tissue was treated with 0.25% sheep
testicular hyaluronidase (Sigma, St Louis, U.S.A.) in DMEM
for 120 min at 37°C. The hyaluronidase solution was then
replaced by 0.25% of Pronase (Streptomyces griseus Pro-
nase E; Merck, Darmstadt, Germany) in DMEM for 90 min
at 37°C. Next, the cartilage was washed twice with DMEM
containing 10% of FCS, and stored overnight in the same
incubation medium at 37°C. The tissue was solubilized the
next day following 3–6 h 0.25% collagenase (type I colla-
genase from Clostridium histolyticum; Sigma) digestion in
DMEM with 10% FCS at 37°C. Cells were then centrifuged
for 10 min at 800 rpm, washed three times in DMEM with
10% FCS, tested for viability (Trypan Blue exclusion test)
and counted. More than 95% of the cells were usually
viable after isolation.Fig. 1. Illustration of the control-rate freezing procedure; ordinate:
temperature during the control-rate freezing procedure; abscissa:
time in minutes. The programmed freezing temperature is given,
with its freezing velocity. The changes in programmed freezing
temperature are closely followed by the temperature in the freezing
chamber and in the sample with decay. White arrow: critical
temperature, where an increase in the sample temperature can be
seen. Black arrow: frozen sample submerged in liquid nitrogen.CONTROL-RATE FREEZING PROCEDURE
The cell suspensions were subjected to a control-rate
freezing procedure in a biological freezer (Scientific Biologi-
cal Freezer, Sy-Lab, Purkersdorf, Austria). The temperature
during the freezing program was measured by two probes:
one probe measured the temperature in the freezing
chamber and one probe measured the temperature of the
incubation medium [DMEM plus different concentrations of
dimethyl sulfoxide (DMSO; Merck)] in a tube placed in the
freezing chamber. The chamber temperature closely fol-
lowed the programmed freezing temperature, while the
sample temperature showed a more constant decay of the
program temperature. This freezing program is outlined
in Fig. 1. The control-rate frozen cell suspension was
immediately submerged in liquid nitrogen for 24 h.
The control-rate freezing program used allowed a slow
decrease of the temperature to 4°C, followed by a shortperiod to equilibrate the cell suspension at this tempera-
ture. A linear decrease of temperature over time (−1°C/
min) was then programmed for the cell suspension to reach
−7°C.
During the decrease to −7°C the cells remain unfrozen
because of supercooling, a phenomenon by which a
sample can be cooled beyond the point where a phase
change should occur18–20. The energy content (Joule/
volume) of the supercooled water in the cells is higher than
that of the water in the partly frozen solution outside the
cell, allowing water to flow out of the cell and to freeze
extracellularly. Cooling in this phase is sufficiently slow to
allow the cell to lose water to dehydrate and not to freeze
intracellularly18–20. Depending on the efficiency of the
supercooling process, phase changes (ice crystal for-
mation) of the intracellular water can occur around the
critical temperature of −7°C. This phenomenon is detected
by an abrupt rise in the sample temperature (Fig. 1, white
arrow). Therefore, after reaching −7°C, a quick decrease
(−18°C/min) in chamber temperature was programmed.
During this period of −25°C chamber temperature the
sample temperature progressively decreased. After this
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decreased to −150°C and the control-rate frozen samples
are then placed in liquid nitrogen at −196°C.OPTIMIZATION OF THE CRYOPRESERVATIVE CONCENTRATION
In donor 1, donor 2 and donor 3, a 57-year-old female, a
42-year-old male and a 24-year-old male, respectively, the
optimal concentration of the cryopreservative DMSO for the
recovery of viable cells after the freezing procedure was
determined. One milliliter aliquots of DMEM supplemented
with 10% FCS containing 1.5×106 chondrocytes, were
placed in a series of cryotubes (Nunc; Gibco). Equal
volumes of five different concentrations [0, 10, 20, 30 and
40% (v/v)] of DMSO in DMEM containing 10% FCS were
slowly added to the cryotubes in order to obtain final
concentrations of 0, 5, 10, 15 and 20% of DMSO, respect-
ively. The cells were then control-rate frozen and kept at
−196°C for 24 h. Thawing was slowly achieved by placing
the tubes in a water bath at 37°C. The chondrocytes were
washed twice with DMEM supplemented with 10% FCS,
and cell viability was determined by the Trypan Blue
exclusion test.CULTURES IN AGAROSE
Chondrocytes of donor 4, a 43-year-old male, and of
donor 5, a 62-year-old male, were cultured in gelled agar-
ose as previously described2, with some modifications6,21.
The cultures were set up in 3.6 ml cryotubes (Nunc). The
agarose used was ultralow-gelling temperature agarose
(Type IX, gelling at <15°C and remelting at >50°C; Sigma),
which is easy to work with at room temperature. Three
percent agarose in distilled water was autoclaved twice for
15 min and stored at 4–8°C prior to use. The cryotubes
were coated with 100 l of this 3% agarose and the coating
was then allowed to gel at 4–8°C. Chondrocyte suspension
cultures were established in 1.5% agarose concentrations.
Three percent (double-concentrated) agarose gel was
melted before use, kept at 37°C and mixed with an equal
volume of 2×DMEM (for 50 ml of 2×DMEM: 1.337 g of
lyophilized DMEM, 0.37 g NaHCO3 and 10 mg of ascor-
bate in 40 ml of distilled water and 10 ml of FCS; the
solution was sterilized through a 0.22 m pore membrane
filter) with 20% of FCS to give the desired concentration of
agarose in DMEM with 10% FCS. 0.1 vol. of the chondro-
cyte suspension was added to 1 vol. of soluble agarose in
DMEM. Coated cryotubes were filled with 300 l of
chondrocyte/agarose suspension and kept at 4–8°C for
15 min to allow the agarose to gel. The final cell density
was approximately 1.5×106 chondrocytes per culture.
Three milliliters of the appropriate incubation medium were
then added and the cultures were placed in an incubator at37°C under 5% CO2 for 2 weeks. Nutrient medium plus
50 g per ml of freshly dissolved ascorbate was replaced
three times weekly.CULTURES IN ALGINATE GEL
From donors 6, 7 and 8, a 27-year-old female, a 40-year-
old male and a 59-year-old male, respectively, chondrocyte
cultures in alginate beads were prepared as described
elsewhere7, with some modifications. Chondrocytes sus-
pended in 1 vol. double-concentrated Hanks’ Balanced
Salts Solution without calcium and magnesium (HBSS;
Gibco) were carefully mixed with an equal volume of 4%
alginate (low-viscosity alginate from Macrocystis pyrifera;
Sigma) in HBSS, and autoclaved for 15 min. The final cell
concentration was 5×106 chondrocytes per ml in 2%
alginate. The chondrocyte/alginate suspension was then
slowly dripped through a 23-gauge needle into a 102 mM
calcium chloride solution. The beads were allowed to
polymerize for 10 min at room temperature. The calcium
chloride was then removed, the beads were washed three
times with 0.15 M sodium chloride and finally cultured in
4 ml of DMEM with 10% FCS and 50 g ascorbate per ml.
The nutrient medium was replaced three times weekly. The
chondrocytes were cultured in a six-well plate with 1×106
cells per culture (each well containing 20 alginate beads;
±50 000 chondrocytes per bead) for 14 days, followed by
an incubation of 0, 2.5, 5 or 10 h with 5% DMSO in the
nutrient medium. These DMSO pre-incubated cells were
then control-rate frozen in 1.0 ml cryotubes with 5% DMSO
in the nutrient medium and kept in liquid nitrogen for 24 h.
Next, the beads were thawed, kept in the nutrient medium
for 24 h to wash out the DMSO, and then cultured for 48 h
in the presence of Na235SO4. As a control, chondrocytes in
alginate beads were pre-incubated with 5% DMSO for the
above-mentioned periods, washed and placed in nutrient
medium supplemented with the radioactive precursor. The
experimental procedure is illustrated in Fig. 2.Fig. 2. The experimental procedure for freezing chondrocytes in alginate beads.QUANTITATIVE DETERMINATION OF TOTAL 35S-LABELED
PROTEOGLYCANS SYNTHESIZED IN AGAROSE CULTURES
35S-incorporation in aggrecan was investigated using
Na235SO4 as a radioactive precursor. In most in vitro
conditions tested so far, most of the 35SO4 used by
phenotypically stable chondrocytes was incorporated in
aggrecan.
After a 2-week culture period, 10 Ci/ml of the label was
included in the incubation medium for 48 h. Newly synthe-
sized 35S-aggrecans partly accumulated in the artificial
intercellular agarose matrix. Another part of these 35S-
macromolecules escaped to the incubation medium. The
344 K. F. Almqvist et al.: Cryopreservation of chondrocytes in alginateagarose was mechanically disrupted and digested in the
culture dish using 3 ml of a 50 U/ml agarase (agarose
3-glycanohydrolase from Pseudomonas atlantica, Sigma)
in 0.067 M phosphatase pH 6.0 in the presence of protein-
ase inhibitors (0.1 M -amino-n-caproic acid, 0.01 M EDTA,
0.005 M benzamidine-chloride and 0.01 M phenylmethyl-
sulphonyl fluoride22) at 40°C overnight. The resulting sus-
pension was centrifuged for 10 min at 1000 rpm. The
incubation medium and the supernatant were pooled at
−20°C for further chromatography.
After centrifugation aliquots of pools of combined media
and agarose digests were desalted through a Sephadex
G25-column (Pharmacia; Uppsala, Sweden) chromatog-
raphy gel in 0.067 M phosphate (K2HPO4/Na2HPO4)
pH 6.8, containing 0.01 M Na2SO4 in order to separate the
35S-labeled aggrecans from the free 35sulfate. The eluted
macromolecular fractions were counted for radioactivity.
The radioactivity under the curves was related to the total
incorporation of 35sulfate in aggrecans by the respective
cultures. Considering the amounts of pooled culture
medium and culture digests that were analysed after
chromatography, the specific activity of the incubation
medium, the decay of 35sulfate, the labeling period in hours
and the numbers of cells per culture, sulfate incorporation
was expressed as pg SO4 incorporated per 1×106
chondrocytes/h23.QUANTITATIVE DETERMINATION OF TOTAL 35S-LABELED
PROTEOGLYCANS SYNTHESIZED IN ALGINATE CULTURES
After a 2-week culture period, 10 Ci/ml of Na235SO4
was included in the incubation medium of the alginate
beads for 48 h. The medium of the cultures was then
aspirated and the alginate beads were washed and dis-
solved by incubation for 10 min with 3 ml of 55 mM tri-
sodium citrate dihydrate pH 6.8, 0.15 M NaCl at 25°C. The
resulting suspension was centrifuged at 900 rpm for 10 min
to separate cells with their cell-associated matrix [(CAM);
the pellet12] from the constituents of the interterritorial
matrix [(ITM); the supernatant]. The CAM was further
extracted by an incubation for 48 h in dissociative con-
ditions with 4 M GuHCl in a 50 mM sodium acetate buffer
pH 5.824, at 4°C in the presence of proteinase inhibitors
(0.1 M -amino-n-caproic acid, 0.01 M EDTA, 0.005 M
benzamidine-chloride and 0.01 M phenylmethylsulphonyl
fluoride)23. This solution was subsequently centrifuged for
10 min at 1000 rpm and the dissociated CAM aggrecans
were recovered in the supernatant. The suspensions and
the media were stored at −20°C for further analysis.
The media and the alginate solutions were separately
desalted using Sephadex G25-column (Pharmacia)
chromatography. In the 0.067 M phosphate buffer the dis-
sociated aggrecans from the CAM were able to reassoci-
ate. The radioactivity of the macromolecular fractions from
the medium, the ITM and the CAM was calculated as
mentioned above.CHROMATOGRAPHY OF PROTEOGLYCANS ON SEPHAROSE CL-2B:
ANALYSIS OF THE 35S-AGGRECAN SUBPOPULATIONS
Pools of the obtained media and digests were desalted
through a Sephadex G25 chromatography gel in order to
separate 35S-labeled aggrecans from free 35sulfate. Frac-
tions containing the 35S-labeled macromolecules were
pooled and used for gel permeation chromatography onSepharose Cl-2B (Pharmacia) in the same buffer. 35S-
labeled macromolecules have been shown to elute in three
fractions: 35S-aggrecan aggregates (Kav: 0.00) and mono-
mers (Kav: 0.12) separated from each other in the first two
peaks6,25. Some low molecular weight material (Kav: 0.71),
the exact nature of which has not been investigated (break-
down products; low-hydrodynamic size aggrecan subpopu-
lations) eluted in the third tailing fraction. The radioactivity
under the two first curves allowed calculation of the
proportions of 35S-aggrecan aggregates and monomers.STATISTICS
The experiments were conducted in three-fold. Mean
values and one standard deviation (1S.D.) were calculated.
Statistical analysis was carried out by the unpaired two-
tailed Mann–Whitney U-test to determine whether variables
were significantly different (P<0.05) in the respective
experiments.ResultsOPTIMAL CRYOPRESERVATIVE CONCENTRATION
The results of control-rate freezing of three different
samples of human chondrocytes in five different concen-
trations of DMSO are presented in Table I. The concen-
tration of 5% DMSO resulted in the highest cell viability as
assayed by Trypan Blue exclusion. Routinely, 65–70% of
cells were recovered after freezing in this 5% DMSO. Cell
viability decreased significantly (P<0.05) when 0, 15 or
20% concentrations of DMSO were used. Ten percent of
DMSO produced no significant decrease in cell viability
when compared to 5% DMSO. This applied to the cells of
two out of the three donors. Consequently, further
freezing experiments were performed in 5% DMSO as
cryopreservative.Table I
Cell viability of chondrocytes after control-rate freezing in different
concentrations of DMSO
Mean cell viability
(% of viable cells)±1 S.D.
Donor 1 Donor 2 Donor 3
DMSO
0% 2.7±1.4* 2.0±1.6* 0.7±0.9*
5% 84.4±2.4 80.0±4.5 95.3±1.2
10% 34.7±6.8* 73.0±3.3 85.3±1.2
15% 19.7±2.0* 27.0±3.9* 42.3±2.0*
20% 17.7±2.7* 11.0±1.2* 20.7±2.0*
Donor 1: 57-year-old female, donor 2: 42-year-old male, donor
3: 24-year-old male.
*Significant difference (P<0.05) in mean cell viability when concen-
trations other than 5% DMSO were used in the experiments.AGGRECAN SYNTHESIS IN AGAROSE CULTURE
Chondrocytes cultured in gelled agarose were used to
evaluate the effects of control-rate freezing in 5% DMSO on
aggrecan synthesis. The agarose culture method was used
because of the experience of this laboratory with this
culture condition.
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cultured in agarose, with or without previous control-rate
freezing. Before culture in agarose, samples of the pre-
viously frozen cells were seeded in monolayer culture
dishes to allow viable cells to attach. After 24 h, floating
(dead) cells were removed and the attached cells were
deattached following a 10-min incubation at 37°C with a
1.0 mg/ml trypsin solution in phosphate-buffered saline.
About 100% of the harvested cells were viable. Another
part of the frozen cells was immediately transferred to the
agarose gel. Synthesis of aggrecans in agarose cultures
was investigated using Na235SO4 as a radioactive
precursor. Aggrecan synthesis was expressed as pg
of SO4 incorporated in aggrecan molecules per 1×106
chondrocytes/h23.
Compared to the control situation SO4 incorporation did
not decrease significantly when the chondrocytes were
frozen in cell suspension in 5% DMSO and subsequently
placed in agarose culture. Also, the chondrocytes which
were kept in the monolayer condition before being cultured
in agarose showed no significant decrease in the synthesis
rate of aggrecans when compared with the non-frozen
chondrocytes in agarose (Table II).AGGRECAN SUBPOPULATIONS IN AGAROSE CULTURES
Sepharose Cl-2B gel permeation chromatography was
performed on the pools of combined agarose digests and
supernatant media obtained from the cultures of two
donors. Percentages of aggrecan in aggregates and in
monomeric form, and of low molecular weight proteoglycan
are listed in Table III. As specified, the 35S-labeled material
from three cultures of each donor was analysed. Coef-
ficients of variation of the results illustrate the high repro-
ducibility of the system. No significant differences (P≥0.05)
were recorded in any of the aggrecan subpopulations when
the control-rate frozen chondrocytes were compared with
the non-frozen chondrocytes.Table II
Aggrecan synthesis by control-rate frozen/thawed chondrocytes
cultured in agarose
Procedure Aggrecan synthesis rates
(pg SO4/1×106 chondrocytes/h)
A B C
Donor 4 5916 (10.4) 5584 (11.3) 5695 (6.3)
Donor 5 4126 (5.4) 3859 (12.3) 2883 (13.6)*
Donor 4: 26-year-old male, donor 5: 43-year-old male. Data are
presented as mean values of three cultures. Coefficients of vari-
ation are in brackets.
A: non-frozen chondrocytes in agarose (control); B: control-rate
frozen chondrocytes cultured in gelled agarose; C: control-rate
freezing followed by the selection of viable cells attaching on the
surface of a culture dish. Attached cells were removed after 24 h
and cultured in gelled agarose.
*Significant difference (P<0.05) when compared to non-frozen
chondrocytes immediately placed in agarose.Table III
Incorporation of 35sulfate in aggrecan aggregates, monomeric aggrecans and low molecular weight proteogly-
cans in chondrocytes cultured in agarose
Procedure Incorporation of 35sulfate in aggrecans
(% of total)
% Aggrecan aggr % Monomeric aggr % Low molecular weight PG
Donor 4 A 40 (4) 38 (2) 22 (4)
B 39 (1) 38 (2) 23 (1)
C 42 (3) 38 (4) 20 (4)
Donor 5 A 35 (1) 32 (2) 33 (3)
B 30 (10) 31 (5) 39 (11)
C 35 (17) 30 (5) 35 (14)
Donor 4: 26-year-old male, donor 5: 43-year-old male. Data are presented as mean values of three cultures.
Coefficients of variation are in brackets.
A: non-frozen chondrocytes in agarose (control); B: control-rate frozen chondrocytes cultured in gelled agarose;
C: control-rate freezing followed by the selection of viable cells attaching on the surface of a culture dish.
Attached cells were removed after 24 h and cultured in gelled agarose.
No significant differences (P≥0.05) were recorded in any of the aggrecan subpopulations when the control-rate
frozen chondrocytes (B and C) were compared with the non-frozen chondrocytes (A). aggr=aggregates;
PG=proteoglycans.AGGRECAN SYNTHESIS IN ALGINATE CULTURE
Compared to the control situation (no pre-incubation with
DMSO) aggrecan synthesis was not altered in the alginate
cultures of the three donors when non-frozen chondrocytes
were incubated with 5% DMSO for 2.5 h, 5 h and 10 h in
5% DMSO. This was true for the CAM, the ITM and the
medium aggrecans (Fig. 3).
When chondrocytes in alginate were pre-incubated for 0,
2.5, 5 and 10 h in 5% DMSO before freezing of the alginate
beads, the ITM aggrecans decreased by 71±4%, 64±4%,
22±13% (mean of three donors) and 19% (one donor)
respectively, compared to the non-frozen control situation.
This decrease was also apparent in the CAM (65±16%,
68±14%, 25±6% and 27%, respectively) and in the
medium (69±4%, 47±11%, 14±10% and 14%, respect-
ively) (Fig. 4). The decrease in aggrecan synthesis
was significant in chondrocytes incubated with 5%
DMSO for 0 or 2.5 h and frozen when compared with the
nonfrozen control situation, and this for the CAM, the ITM
and the nutrient medium in the three donors. This
decrease was not observed when the chondrocytes were
incubated with 5% DMSO for 5 h (or 10 h in one donor)
and compared with the control situation, and this was so for
the three above-mentioned compartments in the three
donors.
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Sepharose Cl-2B gel permeation chromatography per-
formed on the CAM of the alginate cultures after dissocia-
tive condition, on the ITM and on the medium of three
cultures from three different donors showed no significant
decrease of the percentages of aggrecan in aggregates
and in monomeric form when pre-incubated with 5% DMSO
for 2.5, 5 and 10 h, compared with the chondrocytes not
pre-incubated with DMSO (Fig. 5). Nor did the percentages
of the above-mentioned two fractions in the CAM, ITM or
medium change when the chondrocytes were frozen
after having been pre-incubated with 5% DMSO for the
above-mentioned periods (Fig. 6).Fig. 3. Influence of pre-incubation time in 5% DMSO of non-frozen
chondrocytes on aggrecan synthesis. Donor 6: 27-year-old female,
donor 7: 40-year-old male, donor 8: 59-year-old male. Aggrecan
synthesis rates: pg SO4 incorporated by 1×106 chondrocytes/h.
The aggrecan synthesis rates of the chondrocytes cultured in
alginate and incubated for different time periods with 5% DMSO
are compared. Data are presented as mean values of three
cultures+1 S.D. P-value≥0.05 (not significant) in the experiments
when compared with chondrocytes not incubated in 5% DMSO.Fig. 4. Influence of pre-incubation time in 5% DMSO of control-rate
frozen chondrocytes on aggrecan synthesis. Donor 6: 27-year-old
female, donor 7: 40-year-old male, donor 8: 59-year-old male.
Aggrecan synthesis rates: pg SO4 incorporated by 1×106
chondrocytes/h. The aggrecan synthesis rates of the chondrocytes
cultured in alginate and incubated for different time periods with
5% DMSO before freezing are compared with the non-frozen
condition. Data are presented as mean values of three
cultures+1 S.D. *Significant difference (P<0.05) when compared to
nonfrozen chondrocytes (serving as a control) not incubated in 5%
DMSO.Discussion
The main difficulty when working with human chondro-
cytes is the poor availability of these cells for in vitro andin vivo applications. A chondrocyte bank would be of great
help as a permanent source of cartilage cells. This is
certainly true for the clinical use in orthopedic surgery,
where more and more attention is being paid to the repair
of chondral and osteochondral lesions. A chondrocyte bank
would allow the frozen cells to be delivered instantaneously
to the operating theatre. Chondrocytes cultured in alginate,
a matrix that has been used in vivo8, may be a better
choice for repair of the lesions. In order to set up
such a ‘chondrocyte cell’ bank, the method used for
cryopreservation of isolated chondrocytes is of crucial
importance.
Cryopreservation is the technique of freezing and storing
living cells at −196°C in liquid nitrogen19. Once the cells
are at liquid nitrogen temperatures, they remain viable for
years. No thermally driven reactions occur in aqueous
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Osteoarthritis and Cartilage Vol. 9, No. 4 349systems at −196°C18,20,26. The challenge with the
chondrocytes is not the storage at very low temperatures
but rather the lethal effects of passing through an inter-
mediate temperature zone during cooling20. Essential to
cell survival is the avoidance of too rapid an intracellular
freezing. This would enable intracellular ice crystal for-
mation and cell damage. Also of importance during the
freezing procedure is the physicochemical equilibrium
between the intra- and extracellular compartment, which
will be disturbed when rapid freezing of the extracellular
compartment occurs. This rapid freezing produces an
osmotic disequilibrium outside the cell with water escaping
from the cell, resulting in a high concentration of potentially
harmful electrolytes inside the cell. With the control-rate
freezing procedure used, an optimal physicochemical
equilibrium is achieved between the intra- and extracellular
cell compartment with less cell damage and cell death15.
DMSO increases the viscocity of the intracellular liquid
and the intracellular concentration of solutes. These two
phenomena avoid rapid cell shrinkage, which is respon-
sible for cell damage during freezing. On a chemical basis,
DMSO has a high affinity for hydrogen bonds with the
attraction of water to the intracellular compartment27.
Toxic effects of DMSO in concentrations higher than 12%
have been described and the toxicity increases with the
time of exposure15,28–31. Five to ten percent DMSO has
been reported to be the optimal concentration for freezing
of different types of cells15,29–31. We used five different
concentrations of DMSO: 0, 5, 10, 15 and 20% and
found the highest cell viability when the chondrocytes
were control-rate frozen in 5% DMSO. Consequently,
this concentration of 5% DMSO was used in further
experiments.
Although a high cell viability after freezing is important,
the preservation of the chondrocyte phenotype is essential
as well. Frozen chondrocytes were already demonstrated
to produce cartilage-specific aggrecan14. Human articular
chondrocytes cultured in gelled agarose were also shown
to synthesize type II collagen2 and extracellular matrix
aggrecans, of which the glycosaminoglycan population
consisted of chondroitin sulfate and keratan sulfate, but not
of dermatan sulfate6,32. Free hyaluronan chains were not
detected in this in vitro system. These findings indicated
that phenotypically stable cells were maintained in this
ex vivo condition. In our experiments we used Na235SO4 as
a radioactive precursor, and most of this label is incorpor-
ated in aggrecans. In the agarose system we studied the
ITM: 75–80% of the newly synthesized 35S aggrecans
which were recovered from this culture system are found in
this compartment6. The CAM (20–25% of the 35S-activity)
was not investigated in this procedure. We observed a
slight, although non-significant, depression on aggrecan
synthesis rates by chondrocytes in agarose after cryo-
preservation. Varying proportions of dead cells may have
been seeded in the agarose suspension after freeze/
thawing, resulting in a decreased incorporation of 35sulfate
per culture. This problem was not solved by seeding the
chondrocytes in a monolayer for 24 h to exclude the dead
cells after the freeze/thaw procedure, as only viable cells
adhere to the plastic surface.
The relative amounts of aggrecan aggregates and
monomeric aggrecans released by chondrocytes in gelled
agarose were determined by Sepharose Cl-2B gel per-
meation chromatography25. There were no changes in the
proportion of the aggrecan populations released by the
frozen chondrocytes when compared to the aggrecans
produced by non-frozen chondrocytes. This reflects thefunctional stability of the chondrocytes cultured in agarose,
after the freezing procedure.
More recently, the naturally occurring mannuronic acid
alginate has been proposed for the culture of chondrocytes
and other mammalian cells in vitro. A major advantage of
the alginate bead system is the possibility of solubilizing the
beads in a calcium chelator (EDTA, tri-sodium citrate)
allowing the CAM and the ITM to be studied separately.
Solubilizing alginate beads does not interfere with qualita-
tive or quantitative analysis of aggrecan metabolism.
Alginate has also been shown to be biocompatible and
biodegradable8,9 allowing this scaffold to be used in vivo.
The pre-incubation of alginate beads in 5% DMSO for up
to 10 h at 37°C did not alter aggrecan synthesis, as also
has been reported earlier30,31, and this is in contrast to
what has been mentioned by other investigators17. The
decrease of aggrecan synthesis rates after pre-incubation
with DMSO and control-rate freezing could be related to a
time-dependent diffusion of the cryopreservative into the
alginate matrix, resulting in an unequal cooling rate. Donor-
dependent differences in the depression of aggrecan syn-
thesis rates after freezing were also shown, as was also the
case in non-frozen chondrocytes21. A 5-hour pre-incubation
with the cryopreservative was found to be optimal in
preserving aggrecan synthesis rates in the alginate beads
used.
The DMSO itself had no effect on the proportions of
aggrecan aggregates in the alginate culture system. After
the freezing procedure the aggrecan populations remained
unaltered, suggesting that chondrocyte function was not
affected by our freeze/thawing procedure.
The knowledge gained from this study could be applied
to set up a chondrocyte or a ‘chondrocyte cell’ bank using
alginate as artificial matrix. In this manuscript neither the
method to control-rate freeze the chondrocytes nor the
storage of the cells for 24 h in liquid nitrogen resulted in
a high cell mortality or impaired synthetic capacity for
aggrecans by the chondrocytes. It should be mentioned
that the method for long-term preservation of the chondro-
cytes has to be proven.References
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